Stocks and Investing
Stocks and Investing
Thu, August 10, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, August 9, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Scott Fidel Maintained (THC) at Hold with Decreased Target to $17 on, Aug 9th, 2017
Scott Fidel of Credit Suisse, Maintained "Tenet Healthcare Corporation" (THC) at Hold with Decreased Target from $20 to $17 on, Aug 9th, 2017.
Scott has made no other calls on THC in the last 4 months.
There are 3 other peers that have a rating on THC. Out of the 3 peers that are also analyzing THC, 1 agrees with Scott's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Schenker of "Morgan Stanley" Initiated at Hold and Held Target at $19 on, Wednesday, June 7th, 2017
These are the ratings of the 2 analyists that currently disagree with Scott
- Ana Gupte of "Leerink Swann" Upgraded from Hold to Buy and Held Target at $27 on, Wednesday, June 7th, 2017
- Gary Lieberman of "Wells Fargo" Upgraded from Hold to Buy on, Tuesday, June 6th, 2017
Contributing Sources